12 Health Care Stocks Moving In Tuesday's Pre-Market Session
I'm LongbridgeAI, I can summarize articles.In Tuesday's pre-market session, several healthcare stocks showed significant movement. Regentis Biomaterials surged 128.9% to $2.93, while Aditxt and Nuvalent rose over 40%. QTREX Quantum, Icecure Medical, and Cartesian Therapeutics also gained ground. Conversely, iTonic Holdings dropped 34.8%, with MetaVia, Inotiv, Redhill Biopharma, Bio Green Med Solution, and Bluejay Diagnostics declining between 11% and 22%.
Gainers
- Regentis Biomaterials (AMEX:RGNT) stock rose 128.9% to $2.93 during Tuesday's pre-market session. The company's market cap stands at $6.6 million.
- Aditxt (NASDAQ:ADTX) stock rose 44.08% to $0.07.
- Nuvalent (NASDAQ:NUVL) shares rose 38.75% to $122.78. The market value of their outstanding shares is at $6.9 billion.
- QTREX Quantum (NASDAQ:QTEX) stock moved upwards by 20.56% to $1.7. The market value of their outstanding shares is at $61.4 million.
- Icecure Medical (NASDAQ:ICCM) shares increased by 19.5% to $4.35. The company's market cap stands at $295.7 million.
- Cartesian Therapeutics (NASDAQ:RNAC) shares increased by 18.56% to $6.95. The company's market cap stands at $171.7 million.
Losers
- iTonic Holdings (NASDAQ:ITOC) shares decreased by 34.8% to $0.33 during Tuesday's pre-market session. The company's market cap stands at $8.6 million.
- MetaVia (NASDAQ:MTVA) stock decreased by 22.38% to $1.72. The market value of their outstanding shares is at $11.4 million.
- Inotiv (NASDAQ:NOTV) shares declined by 20.35% to $0.09. The company's market cap stands at $3.8 million.
- Redhill Biopharma (NASDAQ:RDHL) shares declined by 18.61% to $0.83. The market value of their outstanding shares is at $5.2 million.
- Bio Green Med Solution (NASDAQ:BGMS) stock decreased by 13.64% to $0.95. The market value of their outstanding shares is at $6.0 million.
- Bluejay Diagnostics (NASDAQ:BJDX) stock fell 11.67% to $4.62. The company's market cap stands at $5.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.